Vitamin D deficiency and metabolic syndrome: any link with statin intolerance and adipokines dysregulation?

Q Medicine
N. Katsiki, A. Sahebkar, M. Banach
{"title":"Vitamin D deficiency and metabolic syndrome: any link with statin intolerance and adipokines dysregulation?","authors":"N. Katsiki, A. Sahebkar, M. Banach","doi":"10.1080/17584299.2016.1243651","DOIUrl":null,"url":null,"abstract":"We read with interest the Miñambres et al. review on hypovitaminosis D and the metabolic syndrome (MetS).[1] The authors describe evidence linking vitamin D (vit D) deficiency with MetS or its components, whereas inconsistent results have been reported with regard to vit D supplementation effects on metabolic parameters. The authors suggested that further research is needed to establish whether improving MetS components can increase vit D levels and vice versa. Vit D deficiency has been associated with statin-induced adverse effects.[reviewed in 2,3] In this context, a recent meta-analysis found that low vit D concentrations were related to myalgia in statin-treated patients.[4] Vit D supplementation has also been proposed as an option to manage statin intolerance in patients with vit D deficiency.[5] As MetS patients are at a high cardiovascular (CV) risk, they are often treated with statins.[6] Based on the link between MetS and vit D hypovitaminosis, it follows that measuring vit D levels may be clinically useful in MetS patients to either prevent or treat statin intolerance. In this context, it is also worth noting that statins can interfere with vit D metabolism through CYP3A4,[7] and also increase the availability of cholesterol biosynthesis precursors such as 7-dehydrocholesterol that mediate vitamin D production.[8] These interactions could confound the association between vit D status and MetS and should be considered before interpreting any observational data. On another issue, MetS has been associated with decreased adiponectin and increased leptin levels.[9] These adipokine abnormalities may further increase CV risk in MetS patients.[9] Vit D metabolism has been reported to influence the expression of leptin and adiponectin in adipose tissue.[10] In this context, there are data linking vit D positively with adiponectin and negatively with leptin levels.[11–13] However, a recent meta-analysis did not find any effect of vit D intake on leptin and adiponectin concentrations.[14] Further research is needed to elucidate such associations.","PeriodicalId":55252,"journal":{"name":"Clinical Lipidology","volume":"15 1","pages":"23 - 24"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lipidology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17584299.2016.1243651","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

We read with interest the Miñambres et al. review on hypovitaminosis D and the metabolic syndrome (MetS).[1] The authors describe evidence linking vitamin D (vit D) deficiency with MetS or its components, whereas inconsistent results have been reported with regard to vit D supplementation effects on metabolic parameters. The authors suggested that further research is needed to establish whether improving MetS components can increase vit D levels and vice versa. Vit D deficiency has been associated with statin-induced adverse effects.[reviewed in 2,3] In this context, a recent meta-analysis found that low vit D concentrations were related to myalgia in statin-treated patients.[4] Vit D supplementation has also been proposed as an option to manage statin intolerance in patients with vit D deficiency.[5] As MetS patients are at a high cardiovascular (CV) risk, they are often treated with statins.[6] Based on the link between MetS and vit D hypovitaminosis, it follows that measuring vit D levels may be clinically useful in MetS patients to either prevent or treat statin intolerance. In this context, it is also worth noting that statins can interfere with vit D metabolism through CYP3A4,[7] and also increase the availability of cholesterol biosynthesis precursors such as 7-dehydrocholesterol that mediate vitamin D production.[8] These interactions could confound the association between vit D status and MetS and should be considered before interpreting any observational data. On another issue, MetS has been associated with decreased adiponectin and increased leptin levels.[9] These adipokine abnormalities may further increase CV risk in MetS patients.[9] Vit D metabolism has been reported to influence the expression of leptin and adiponectin in adipose tissue.[10] In this context, there are data linking vit D positively with adiponectin and negatively with leptin levels.[11–13] However, a recent meta-analysis did not find any effect of vit D intake on leptin and adiponectin concentrations.[14] Further research is needed to elucidate such associations.
维生素D缺乏和代谢综合征:与他汀类药物不耐受和脂肪因子失调有关吗?
我们饶有兴趣地阅读了Miñambres等人关于维生素D缺乏症和代谢综合征(MetS)的综述[1]。作者描述了维生素D (vit D)缺乏与MetS或其成分相关的证据,而关于维生素D补充对代谢参数的影响的不一致的结果已被报道。作者建议需要进一步的研究来确定改善MetS成分是否可以增加维生素D水平,反之亦然。维生素D缺乏与他汀类药物引起的不良反应有关。在这种情况下,最近的一项荟萃分析发现,低维生素D浓度与他汀类药物治疗患者的肌痛有关[4]。补充维生素D也被提议作为治疗维生素D缺乏症患者他汀类药物不耐受的一种选择。[5]由于MetS患者心血管(CV)风险高,他们通常使用他汀类药物治疗。[6]基于MetS和维生素D缺乏症之间的联系,测量维生素D水平可能对MetS患者预防或治疗他汀类药物不耐受有临床意义。在这种情况下,同样值得注意的是,他汀类药物可以通过CYP3A4干扰维生素D的代谢[7],并增加胆固醇生物合成前体的可用性,如介导维生素D生成的7-脱氢胆固醇[8]。这些相互作用可能混淆维生素D状态和MetS之间的关联,在解释任何观测数据之前应该考虑。另一个问题是,MetS与脂联素降低和瘦素水平升高有关。[9]这些脂肪因子异常可能进一步增加MetS患者的CV风险。[9]据报道,维生素D代谢会影响脂肪组织中瘦素和脂联素的表达。[10]在这种情况下,有数据表明维生素D与脂联素水平呈正相关,与瘦素水平呈负相关。[11-13]然而,最近的一项荟萃分析并未发现维生素D摄入量对瘦素和脂联素浓度有任何影响。[14]需要进一步的研究来阐明这些关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Lipidology
Clinical Lipidology 生物-生化与分子生物学
CiteScore
0.44
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
期刊介绍: The Journal of Clinical Lipidology is published to support the diverse array of medical professionals who work to reduce the incidence of morbidity and mortality from dyslipidemia and associated disorders of lipid metabolism. The Journal''s readership encompasses a broad cross-section of the medical community, including cardiologists, endocrinologists, and primary care physicians, as well as those involved in the treatment of such disorders as diabetes, hypertension, and obesity. The Journal also addresses allied health professionals who treat the patient base described above, such as pharmacists, nurse practitioners and dietitians. Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信